Pulse Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,740 |
Gross Profit | -267 | -266 | -299 | 1,436 |
EBITDA | -13,361 | -11,428 | -10,316 | -12,229 |
EBIT | -13,655 | -11,694 | -10,615 | -12,533 |
Net Income | -12,680 | -11,383 | -10,137 | -11,933 |
Net Change In Cash | 0 | 0 | 0 | 1,740 |
Free Cash Flow | -9,062 | -8,424 | -9,785 | -6,819 |
Cash | 79,033 | 26,196 | 34,885 | 44,365 |
Basic Shares | 61,066 | 57,180 | 55,172 | 55,058 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $-9 | $700 | $1,418 | $114 |
Gross Profit | -1,207 | -11,244 | -550 | -665 |
EBITDA | -42,367 | -56,702 | -61,868 | -48,870 |
EBIT | -43,574 | -58,057 | -63,014 | -49,965 |
Net Income | -42,210 | -58,953 | -63,160 | -49,737 |
Net Change In Cash | -9 | 700 | 1,418 | 114 |
Cost of Revenue | 5,564 | |||
Free Cash Flow | -33,162 | -47,414 | -54,534 | -35,806 |
Cash | 44,365 | 61,139 | 28,614 | 12,463 |
Basic Shares | 48,038 | 33,935 | 27,964 | 23,248 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.20 |
2024-06-30 | -$0.19 |
2024-03-31 | -$0.18 |
2023-12-31 | -$0.21 |
